Cerebras Systems (NASDAQ:CBRS) trades at $96.36, sitting 69% below its first trading day price, and shares lost 42.1% over the past month and 11.74% in the most recent trading day alone. The article attributes the decline to the post-IPO lockup ending, with the stock falling below its $185 IPO price as insiders filed to sell more than $84 million in shares, reports questioning whether OpenAI was running its newest fast model on rival hardware, and Culper Research disclosing a short position claiming Cerebras chips may last only 1.5 to 2.5 years. Law firms opened investigations, and TD Cowen cut its target from $275 to $175. Earlier results showed Q2 GAAP revenue of $180.11M below the $193.55M consensus, GAAP EPS of -$2.98 missing the -$0.1801 estimate, and core gross margin sliding to 40.6% from 46.5% the quarter before. Despite this, Craig-Hallum initiated coverage with a Buy rating and a $325.00 target implying 237.3% upside, and ten of 11 analysts still rate Cerebras a Buy, citing its wafer-scale design that bypasses HBM memory and CoWoS packaging bottlenecks. The average Wall Street price target of $282.55 implies 193.2% upside. Cerebras raised $6.4B